Xenopax for the treatment of steroid-refractory acute graft-versus-host disease: the RELAX study

Le-Qing Cao; Wen-Xuan Huo; Er-Lie Jiang; Yue-Wen Fu; Xiao-Jun Xu; Ping-Chong Lei; Ming-Feng Zhao; Zhi Chen; Shu-Xia Guo; Xiao-Bing Huang; Yan-Ming Zhang; Xian-Jing Wang; Guan-Chen Bai; Feng-Bo Jin; Qing-Sheng Li; Ming-Yang Deng; Hao Zhang; Xin-Feng Wang; Xiao-Jun Huang; Xiao-Dong Mo

doi:10.1186/s40779-025-00640-0

您当前的位置：

首页 >

文章列表页 >

Xenopax for the treatment of steroid-refractory acute graft-versus-host disease: the RELAX study

RESEARCH | 更新时间：2026-05-08

- Xenopax for the treatment of steroid-refractory acute graft-versus-host disease: the RELAX study
- Xenopax for the treatment of steroid-refractory acute graft-versus-host disease: the RELAX study
- Le-Qing Cao ，Wen-Xuan Huo ，Er-Lie Jiang ，Yue-Wen Fu ，Xiao-Jun Xu ，Ping-Chong Lei ，Ming-Feng Zhao ，Zhi Chen ，Shu-Xia Guo ，Xiao-Bing Huang ，Yan-Ming Zhang ，Xian-Jing Wang ，Guan-Chen Bai ，Feng-Bo Jin ，Qing-Sheng Li ，Ming-Yang Deng ，Hao Zhang ，Xin-Feng Wang ，Xiao-Jun Huang ，Xiao-Dong Mo
- Military Medical Research 2026年13卷第3期页码：400-412
- 作者机构：
  1.Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing 100044, China
  2.State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China
  3.Department of Hematology, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
  4.Children’s Hospital, Zhejiang University School of Medicine and National Clinical Research Center for Child Health, Hangzhou 310052, China
  5.Department of Hematology, Henan Provincial People’s Hospital, Zhengzhou 450003, China
  6.Department of Hematology, Tianjin First Central Hospital, Tianjin 300192, China
  7.Department of Hematology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430016, China
  8.Department of Hematology, People’s Hospital of Zhengzhou, Zhengzhou 450003, China
  9.Department of Hematology, Sichuan Provincial People’s Hospital, Affiliated Hospital of University of Electronic Science and Technology of China, Chengdu 610072, China
  10.Department of Hematology, Huai’an Second People’s Hospital, Huai’an 223002, Jiangsu, China
  11.Department of Hematology, the Third People’s Hospital of Zhengzhou, Zhengzhou 450003, China
  12.Department of Hematology, the Affiliated Tai’an City Central Hospital of Qingdao University, Tai’an 271000, Shandong, China
  13.Anhui Public Health Clinical Center, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
  14.The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
  15.Department of Hematology, the Second Xiangya Hospital, Central South University, Changsha 410011, China
  16.Department of Hematology, Affiliated Hospital of Jining Medical University, Jining 272067, Shandong, China
  17.Department of Hematology, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu, China
  18.Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China
- 作者简介：
  * Xiao-Dong Mo moxiaodong@pkuph.edu.cn
- 基金信息：
  the Beijing Natural Science Foundation(Z230016);the National Key Research and Development Program of China(2022YFA1103300;2022YFC2502606);the Major Program of the National Natural Science Foundation of China(82293630);the Peking University Medicine Fund for World’s Leading Discipline or Discipline Cluster Development(71003Y3035);the Plan Project of Tongzhou Municipal Science and Technology(KJ2024CX045);the National Natural Science Foundation of China(82170208);the Talent Development Plan for the Future in Medical-Engineering Integration by the Beijing Research Association for Chronic Diseases Control and Health Education (BRA-CDCHE);the Fundamental Research Funds for the Central Universities
- DOI： 10.1186/s40779-025-00640-0
  中图分类号：
- 录用：2025-08-08 ，
- 稿件说明：
移动端阅览
DOI：
DOI：

HTML全文
图( 2 ) 表( 3 )
参考文献
出版信息
数据统计

摘要

Abstract

关键词

Keywords

references

61

浏览量

39

下载量

0

CSCD

文章被引用时，请邮件提醒。

提交

工具集

BibTeX下载
Endnote下载
RefMan 下载
NoteExpress下载
NoteFirst下载

关联资源

Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients

Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies

Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies

Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain